Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03402919Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

Role: collaborator

NCT05669495Unknown

ANNE Vital Sign System Remote Sleep Assessment

Role: collaborator

NCT04109963Phase 2Unknown

Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment

Role: collaborator

NCT03557593Not ApplicableCompleted

Optimizing Prescribing of Antipsychotics in Long-Term Care

Role: collaborator

All 4 trials loaded